PE20040496A1 - Tabletas dispersables que comprenden un derivado de acido benzoico - Google Patents
Tabletas dispersables que comprenden un derivado de acido benzoicoInfo
- Publication number
- PE20040496A1 PE20040496A1 PE2003001051A PE2003001051A PE20040496A1 PE 20040496 A1 PE20040496 A1 PE 20040496A1 PE 2003001051 A PE2003001051 A PE 2003001051A PE 2003001051 A PE2003001051 A PE 2003001051A PE 20040496 A1 PE20040496 A1 PE 20040496A1
- Authority
- PE
- Peru
- Prior art keywords
- tablet
- pharmaceutically acceptable
- acceptable excipient
- weight
- lubricant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Abstract
QUE COMPRENDEN: A)UN COMPUESTO DE FORMULA (I), O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, EN UN CANTIDAD DE 5% A 40%, EN PESO, BASANDOSE EN EL PESO TOTAL DE LA TABLETA; Y, B)AL MENOS UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE, QUE PUEDE SER: i)DE 35% A 55% DE AL MENOS UN RELLENO; ii)DE 10% A 35%, EN PESO DE UN DESINTEGRANTE; iii)DE 1,5% A 5%, DE UN AGLUTINANTE; iv)DE 0,2% A 1%, DE UN TENSOACTIVO; v)DE 0,1% A 0,5% DE UN ABRILLANTADOR; Y, vi)MENOR A APROXIMADAMENTE 0,4% DE UN LUBRICANTE, TAL COMO ESTEARATO DE MAGNESIO, BASANDOSE TODOS LOS PORCENTAJES EN EL PESO TOTAL DE LA TABLETA. DONDE, EL TIEMPO DE DESINTEGRACION DE LA TABLETA ES DE 5 MINUTOS O MENOS. SE REFIERE TAMBIEN AL PROCESO PARA LA PREPARACION DE LAS TABLETAS, QUE COMPRENDE: 1)MEZCLAR EL COMPUESTO (I) O UNA SAL DEL MISMO CON AL MENOS UN EXCIPIENTE ACEPTABLE; 2)GRANULAR EN HUMEDO LA MEZCLA OBTENIDA; 3)MEZCLAR LOS GRANULADOS OBTENIDOS CON UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE PARA FORMAR UNA MEZCLA; Y, 4)ROCIAR EL LUBRICANTE SOBRE LAS SUPERFICIES DE CONTACTO CON LOS MATERIALES DE LAS HERRAMIENTAS DE PRENSA DE LA MAQUINA FORMADORA DE TABLETAS Y COMPRIMIR LA MEZCLA OBTENIDA EN EL PASO (3) PARA FORMAR UNA TABLETA. TIENE APLICACION EN EL TRATAMIENTO DE SOBRECARGA DE HIERRO EN LAS ANEMIAS DEPENDIENTES DE TRANSFUSION, COMO TALASEMIA MAYOR, TALASEMIA INTERMEDIA Y SIMILARES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0223978.8A GB0223978D0 (en) | 2002-10-15 | 2002-10-15 | Organic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20040496A1 true PE20040496A1 (es) | 2004-09-20 |
Family
ID=9945957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2003001051A PE20040496A1 (es) | 2002-10-15 | 2003-10-14 | Tabletas dispersables que comprenden un derivado de acido benzoico |
Country Status (34)
Country | Link |
---|---|
US (5) | US20060110446A1 (es) |
EP (1) | EP1556013B8 (es) |
JP (4) | JP2006504748A (es) |
KR (1) | KR100765580B1 (es) |
CN (2) | CN101912391A (es) |
AR (1) | AR041609A1 (es) |
AT (1) | ATE431138T1 (es) |
AU (1) | AU2003278078B2 (es) |
BR (1) | BR0315264A (es) |
CA (1) | CA2501659C (es) |
CY (1) | CY1109902T1 (es) |
DE (1) | DE60327646D1 (es) |
DK (1) | DK1556013T3 (es) |
EC (1) | ECSP055733A (es) |
EG (1) | EG25453A (es) |
ES (1) | ES2326167T3 (es) |
GB (1) | GB0223978D0 (es) |
HK (1) | HK1081101A1 (es) |
IL (1) | IL167709A (es) |
JO (1) | JO2700B1 (es) |
MX (1) | MXPA05003999A (es) |
MY (1) | MY140999A (es) |
NO (1) | NO336958B1 (es) |
NZ (1) | NZ539354A (es) |
PA (1) | PA8586501A1 (es) |
PE (1) | PE20040496A1 (es) |
PL (1) | PL213325B1 (es) |
PT (1) | PT1556013E (es) |
RU (1) | RU2338532C2 (es) |
SI (1) | SI1556013T1 (es) |
TN (1) | TNSN05109A1 (es) |
TW (1) | TWI339657B (es) |
WO (1) | WO2004035026A1 (es) |
ZA (1) | ZA200502488B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0408078D0 (en) * | 2004-04-08 | 2004-05-12 | Novartis Ag | Organic compounds |
JP2009512652A (ja) * | 2005-10-19 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | 安息香酸誘導体含有分散錠 |
US20090317489A1 (en) | 2006-05-09 | 2009-12-24 | Hanspeter Nick | Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof |
TWI448285B (zh) | 2006-07-13 | 2014-08-11 | Los Angeles Biomed Res Inst | 用以治療白黴菌症(mucormycosis)及其他真菌類疾病之組合物及方法 |
EP1994930A1 (en) | 2007-05-22 | 2008-11-26 | Novartis AG | Triazol compounds for treating biofilm formation |
WO2009016359A1 (en) * | 2007-07-27 | 2009-02-05 | Pliva Hrvatska D.O.O. | New forms of deferasirox |
EP2062572A1 (en) | 2007-11-19 | 2009-05-27 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions |
WO2009106824A2 (en) * | 2008-02-25 | 2009-09-03 | Cipla Limited | Pharmaceutical formulations |
JPWO2010032489A1 (ja) | 2008-09-22 | 2012-02-09 | 国立大学法人旭川医科大学 | 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法 |
WO2010092419A1 (en) | 2009-02-12 | 2010-08-19 | Assistance Publique - Hopitaux De Paris | Combined treatment of multiple sclerosis |
WO2010107500A1 (en) | 2009-03-19 | 2010-09-23 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
ES2543427T3 (es) | 2010-07-08 | 2015-08-19 | Ratiopharm Gmbh | Forma farmacéutica oral de deferasirox |
PE20170468A1 (es) | 2010-10-01 | 2017-04-26 | Cipla Ltd | Composicion farmaceutica que comprende deferasirox |
EP2664333B1 (en) | 2011-01-14 | 2016-10-12 | Disease Adsorption System Technologies Co., Ltd. | Polymeric iron chelating agent |
AU2013343250A1 (en) | 2012-11-12 | 2015-04-09 | Cipla Limited | Fixed dose pharmaceutical composition comprising deferasirox and deferipone |
NZ711179A (en) | 2013-03-08 | 2018-07-27 | Novartis Ag | Oral formulations of deferasirox |
AU2014264421A1 (en) | 2013-05-10 | 2015-12-03 | Cipla Limited | Low dose pharmaceutical composition |
CN103735519A (zh) * | 2014-01-10 | 2014-04-23 | 无锡万全医药技术有限公司 | 一种地拉罗司颗粒剂及其制备方法 |
EP2987482A1 (en) | 2014-08-22 | 2016-02-24 | Santa Farma Ilaç Sanayi A.S. | Soluble and dispersible pharamaceutical deferasirox formulation |
KR20160088965A (ko) | 2015-01-16 | 2016-07-27 | 대원제약주식회사 | 데페라시록스를 함유하는 현탁제 |
WO2016167729A1 (en) | 2015-04-16 | 2016-10-20 | Öğün Yusuf Toktamiş | Dispersible tablets comprising deferasirox |
EP3095443A1 (en) | 2015-05-21 | 2016-11-23 | Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. | Pharmaceutical composition comprising deferasirox |
KR101695970B1 (ko) | 2015-07-31 | 2017-01-13 | 건일제약 주식회사 | 데페라시록스 함유 산제 및 그 제조방법 |
US20190091204A1 (en) | 2016-03-17 | 2019-03-28 | Lupin Limited | Compositions of deferasirox |
EP3248594A1 (en) * | 2016-05-25 | 2017-11-29 | ratiopharm GmbH | Tablet for multiple oral applications |
EP3518904A1 (en) | 2016-09-30 | 2019-08-07 | Synthon B.V. | Pharmaceutical composition comprising deferasirox |
WO2018208242A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation of deferasirox tablet for oral suspension composition with better processability |
TR201707764A2 (tr) * | 2017-05-29 | 2018-12-21 | Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi | Deferasiroksun bölünebilir tablet formları. |
EP3675832A1 (en) | 2017-09-01 | 2020-07-08 | Jordan Sweden Medical and Sterilization Company | Fast self dispersible dosage forms of deferasirox |
WO2019108157A1 (en) * | 2017-11-28 | 2019-06-06 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A scored tablet formulation in a dispersible form comprising deferasirox |
WO2019108156A1 (en) * | 2017-11-28 | 2019-06-06 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A scored tablet formulation comprising deferasirox in a film tablet form |
TR201722910A2 (tr) * | 2017-12-29 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari |
KR20190110771A (ko) | 2018-03-21 | 2019-10-01 | 주식회사 한국팜비오 | 데페라시록스를 함유하는 소형 분산성 정제 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU120988A (en) * | 1988-06-23 | 1990-06-30 | Lek Tovarna Farmacevtskih | Process for preparing new dispersion pills of cimetidine |
YU183988A (en) * | 1988-09-30 | 1990-08-31 | Lek Tovarna Farmacevtskih | Process for preparing dispersion pills of dihydroergotoxine |
MY110880A (en) * | 1991-01-30 | 1999-06-30 | The Wellcome Foundation Ltd | Water-dispersible tablets |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
GB9215908D0 (en) * | 1992-07-27 | 1992-09-09 | Wellcome Found | Water dispersible tablets |
DE4412117A1 (de) * | 1994-04-08 | 1995-10-12 | Fette Wilhelm Gmbh | Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen |
TW533205B (en) * | 1996-06-25 | 2003-05-21 | Novartis Ag | Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition |
JP4117811B2 (ja) * | 1997-04-22 | 2008-07-16 | 日本化薬株式会社 | フルタミド製剤及びその製法 |
KR20010042536A (ko) * | 1998-04-08 | 2001-05-25 | 히라타 다다시 | 정제의 제조방법 및 정제 |
JP2000063269A (ja) * | 1998-08-20 | 2000-02-29 | Taiho Yakuhin Kogyo Kk | 固形製剤 |
JP2000086503A (ja) * | 1998-09-07 | 2000-03-28 | Pola Chem Ind Inc | 錠剤医薬組成物 |
KR100720877B1 (ko) * | 1998-12-28 | 2007-05-22 | 다케다 야쿠힌 고교 가부시키가이샤 | 비타민 제제 |
FR2793690B1 (fr) * | 1999-03-30 | 2003-01-03 | Cll Pharma | Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique |
JP2002033764A (ja) * | 2000-07-14 | 2002-01-31 | Fujitsu Ltd | 通信サービス提供システム、並びに通信サービス提供システムにおいて使用される移動端末装置、アドレスサーバ装置、およびルータ装置 |
JP4886107B2 (ja) * | 2000-10-13 | 2012-02-29 | サンスター株式会社 | 歯周病予防用口腔内溶解錠 |
-
2002
- 2002-10-15 GB GBGB0223978.8A patent/GB0223978D0/en not_active Ceased
-
2003
- 2003-10-14 WO PCT/EP2003/011351 patent/WO2004035026A1/en active IP Right Grant
- 2003-10-14 PL PL375166A patent/PL213325B1/pl unknown
- 2003-10-14 US US10/530,856 patent/US20060110446A1/en not_active Abandoned
- 2003-10-14 JP JP2004544211A patent/JP2006504748A/ja not_active Withdrawn
- 2003-10-14 CN CN2010102595386A patent/CN101912391A/zh active Pending
- 2003-10-14 DK DK03769384T patent/DK1556013T3/da active
- 2003-10-14 ES ES03769384T patent/ES2326167T3/es not_active Expired - Lifetime
- 2003-10-14 AR ARP030103734A patent/AR041609A1/es not_active Application Discontinuation
- 2003-10-14 EP EP03769384A patent/EP1556013B8/en not_active Expired - Lifetime
- 2003-10-14 PE PE2003001051A patent/PE20040496A1/es not_active Application Discontinuation
- 2003-10-14 MX MXPA05003999A patent/MXPA05003999A/es active IP Right Grant
- 2003-10-14 RU RU2005114904/15A patent/RU2338532C2/ru active
- 2003-10-14 NZ NZ539354A patent/NZ539354A/en not_active IP Right Cessation
- 2003-10-14 TW TW092128451A patent/TWI339657B/zh not_active IP Right Cessation
- 2003-10-14 MY MYPI20033898A patent/MY140999A/en unknown
- 2003-10-14 AT AT03769384T patent/ATE431138T1/de active
- 2003-10-14 PT PT03769384T patent/PT1556013E/pt unknown
- 2003-10-14 SI SI200331642T patent/SI1556013T1/sl unknown
- 2003-10-14 CA CA2501659A patent/CA2501659C/en not_active Expired - Lifetime
- 2003-10-14 AU AU2003278078A patent/AU2003278078B2/en not_active Expired
- 2003-10-14 DE DE60327646T patent/DE60327646D1/de not_active Expired - Lifetime
- 2003-10-14 KR KR1020057006452A patent/KR100765580B1/ko active IP Right Review Request
- 2003-10-14 BR BR0315264-2A patent/BR0315264A/pt not_active Application Discontinuation
- 2003-10-14 CN CNA2003801014675A patent/CN1705471A/zh active Pending
- 2003-10-15 JO JO2003137A patent/JO2700B1/en active
- 2003-10-15 PA PA20038586501A patent/PA8586501A1/es unknown
-
2005
- 2005-03-28 IL IL167709A patent/IL167709A/en active IP Right Grant
- 2005-03-29 ZA ZA2005/02488A patent/ZA200502488B/en unknown
- 2005-04-12 EG EGNA2005000130 patent/EG25453A/xx active
- 2005-04-14 TN TNP2005000109A patent/TNSN05109A1/en unknown
- 2005-04-15 EC EC2005005733A patent/ECSP055733A/es unknown
- 2005-05-12 NO NO20052335A patent/NO336958B1/no not_active IP Right Cessation
-
2006
- 2006-01-24 HK HK06101089.4A patent/HK1081101A1/xx not_active IP Right Cessation
-
2009
- 2009-08-12 CY CY20091100872T patent/CY1109902T1/el unknown
- 2009-09-28 JP JP2009222652A patent/JP2010031022A/ja active Pending
-
2010
- 2010-11-04 US US12/939,631 patent/US20110046193A1/en not_active Abandoned
-
2011
- 2011-09-07 US US13/227,033 patent/US20110319457A1/en not_active Abandoned
-
2012
- 2012-04-09 US US13/442,189 patent/US20120196909A1/en not_active Abandoned
-
2014
- 2014-01-06 JP JP2014000329A patent/JP5908505B2/ja not_active Expired - Lifetime
-
2015
- 2015-12-04 JP JP2015237802A patent/JP2016094435A/ja active Pending
-
2016
- 2016-02-26 US US15/054,899 patent/US20160175255A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20040496A1 (es) | Tabletas dispersables que comprenden un derivado de acido benzoico | |
BR9808429A (pt) | Composição farmacêutica e processo para a sua preparação. | |
AR054382A1 (es) | Formulacion de compresion directa de un inhibidor de dipeptidil-peptidasa iv y una glitazona y proceso | |
TW200518743A (en) | Rapid dissolution formulation of a calcium receptor-active compound | |
CO5390076A1 (es) | Composiciones farmaceuticas | |
AR049000A1 (es) | Formulacion para compresion directa y proceso para la preparacion de una tableta directamente comprimida | |
AR054383A1 (es) | Formulacion de 1-((3- hidroxi-adamant-1- ilamino - acetil) - pirroldin-2-(s) -carbonitrilo de liberacion modificada | |
MA29171B1 (fr) | Formulation a compression directe et procede associe | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
WO2006082501A3 (en) | Fast wet-massing method for the preparation of calcium-containing compositions | |
UY27368A1 (es) | Nuevos compuestos | |
BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
TN2012000246A1 (en) | Pharmaceutical compositions comprising sigma receptor ligands | |
IL187591A0 (en) | Pharmaceutical composition as solid dosage from and method for manufacturing thereof | |
BR9915702A (pt) | Tablete detergente de composição particulado comprimido, e, processo para fabricar o mesmo | |
EA200301040A1 (ru) | Способ производства фармацевтической композиции низкой дозы | |
TNSN07013A1 (en) | Anti-histaminic composition | |
UA95274C2 (ru) | Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления | |
TNSN05203A1 (fr) | Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede | |
MX2023004835A (es) | Metodo para la preparacion de la composicion cristalina y farmaceutica acido 1-(3-ciano-1-isopropil-indol-5-yl)pirazol-4-car boxilico que lo comprende. | |
AR111434A2 (es) | Material granular, cápsula resistente al agua, comprimido compactado de material granular, proceso para preparar el material granular y usos | |
RU2009135981A (ru) | Фармацевтические композиции, содержащие ирбесартан | |
TN2010000120A1 (en) | Galenical formulations of organic compounds | |
IS6315A (is) | Fósínópríl lyfjasamsetning | |
PE35498A1 (es) | Formulacion farmaceutica de famciclovir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |